Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Zhang, J., et al., Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management
At 6'1" and 183 pounds, Turner, a 44-year-old entrepreneur from Charlotte, North Carolina, with a finance background, wasnt interested in weight loss
Prednisone can cause appetite stimulation and gastric irritation, while GLP-1 medications cause nausea and reduced appetite
This proactive approach engages members earlier, meaning they are more likely to seek care before reaching a high acuity level, which is a key component of our Living Health strategy. Nearly 2 million Highmark members are eligible for Noom: Weight Management as part of their medical benefits with no additional, out-of-pocket cost
US$ 25.35
US$ 24.65
US$ 27.86
US$ 27.54
US$ 23.80
US$ 25.97
US$ 27.86
US$ 25.04
US$ 24.76
US$ 22.81
US$ 21.07
